Icu Medical (ICUI) Cash from Financing Activities (2009 - 2026)

Icu Medical has reported Cash from Financing Activities for 18 years, with the latest figure at -$44.1 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities rose 21.68% year-over-year to -$44.1 million; the trailing twelve-month figure through Mar 2026 stood at -$299.3 million (down 250.93% YoY), and the FY2025 full-year result was -$311.5 million, down 458.29% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$44.1 million, down from -$34.5 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $1.6 billion in Q1 2022, with the low at -$195.0 million in Q2 2025.
• Historically, Cash from Financing Activities has averaged $70.0 million across 5 years, with a median of -$10.4 million in 2024.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities soared 55063.9% — and 2025, when it sank 1778.03%.
• Icu Medical's Cash from Financing Activities stood at -$10.4 million in 2022, then increased by 24.42% to -$7.8 million in 2023, then fell by 4.36% to -$8.2 million in 2024, then tumbled by 321.01% to -$34.5 million in 2025, then slipped by 27.95% to -$44.1 million in 2026.
• The last three Cash from Financing Activities figures came in at -$44.1 million (Q1 2026), -$34.5 million (Q4 2025), and -$25.7 million (Q3 2025), per Business Quant data.